Cancer Archives

News and Trends 8 Jul 2022

Cancer therapeutics company’s double win with $25M funding, and appointment of new board member

An mRNA-technology company developing cancer therapeutics designed to improve patients’ survival rate and quality of life — this week announced the completion of a $25 million Series A financing. Kernal Biologics, Inc. (Kernal Bio) confirmed that the funding was led by Hummingbird Ventures. Amgen Ventures, HBM Genomics and Civilization Ventures along with other venture capitalists, family offices and […]

July 8, 2022 - 3 minutesmins - By Liza Laws

More News! 8 Jul 2022

Beyond Biotech podcast 4: CorePath, Rensselaer, Versameb

This week’s guests are: Helen Zha, assistant professor of chemical and biological engineering and a member of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute; Versameb CEO Klaas Zuideveld; and Aamir Ehsan, CEO and medical director of CorePath and Celina Villa, medical director of Biopharma Division. Versameb gives presentation during World […]

July 8, 2022 - 6 minutesmins - By Jim Cornall

News and Trends 8 Jul 2022

World’s first research project for an early detection, multi-cancer screening test launched in Singapore

A project for the discovery and validation of new combinations of biomarkers that can detect multi-cancer early has been launched in Singapore. Biotechnology company, MiRXES Ptr Ltd, announced this week the signing of a memorandum of understanding signaling the launch of Project CADENCE (Cancer Detected Early caN be CurEd). It is the world’s first large-scale […]

July 8, 2022 - 4 minutesmins - By Liza Laws

News and Trends 5 Jul 2022

Destiny Pharma announces start of new oral mucositis research program

Oral mucositis is a common and devastating complication from chemotherapy and radiotherapy suffered by more than 2 million cancer patients every year. Destiny Pharma plc, a clinical-stage biotech company focused on the development of novel medicines that can prevent life-threatening infections, has started a new research program on the condition. The research study will be […]

July 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 5 Jul 2022

AstraZeneca adds to its treatments for blood cancer with $100M deal

AstraZeneca announced today (July 5) it has agreed to buy a company working on a cancer cure. The company will hand over $100 million for TeneoTwo, Inc. in an upfront payment that will include its phase 1 clinical-stage CD19/CD3 T-cell engager, TNB-486, that is being evaluated in relapsed and refractory B-cell non-Hodgkin lymphoma. With the […]

July 5, 2022 - 2 minutesmins - By Liza Laws

News and Trends 4 Jul 2022

Nanoparticle can kill cancer cells and aid muscle relaxation

A nanoparticle that is both a nanoheater and a nanothermometer at the same time has been developed by researchers at a Japanese university. The university said this is a significant development that not only aids muscle relaxation, but it can also kill cancer cells. Satoshi Arai and colleagues at Kanazawa University have successfully showed that […]

July 4, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

License submitted to FDA for drug to help those with large B-cell lymphoma

A biologics license application has been submitted to the US Food and Drug Administration (FDA) for an antibody to treat patients with B-cell lymphoma. Genmab A/S is a biotechnology company that says its core purpose is to improve the lives of people with cancer. Recently it announced its intent to submit the application for subcutaneous […]

July 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

On this week’s podcast, we have three conversations: with Manfred Rüdiger, CEO of Ariceum Therapeutics; Jon Hague, Unilever’s R&D VP for homecare; and Olivier Rolland, executive director at TWB. Ambrosia and Dionymer winners at 2022 TWB Start-Up Day TWB, which sets up industrial biotechnology R&D projects and designer of innovative and sustainable solutions, announces the […]

July 1, 2022 - 9 minutesmins - By Jim Cornall

News and Trends 28 Jun 2022

Companies unite to bolster diagnostics for cancer and liver disease

Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease and breast cancer have partnered in a bid to bolster noninvasive diagnostics for the conditions. IV Bio-holdings (IVBH), a clinical-stage bio-platform company that conceives, creates and scales first-generation precision health solutions that improves the detection, diagnosis and treatment of disease […]

June 28, 2022 - 2 minutesmins - By Liza Laws

Kintor Pharmaceutical drug gets positive results for breast cancer

News and Trends 28 Jun 2022

Breast cancer drug recommended for approval

A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of disease progression or even death by 72%, has been recommended for approval in the European Union (EU). The drug containing trastuzumab deruxtecan is specifically engineered for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer treated with […]

June 28, 2022 - 3 minutesmins - By Liza Laws

News and Trends 28 Jun 2022

Trinity, St. James’s and Legend Biotech collaborating on solid tumors

Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic collaboration with Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies. Together, they will develop 3D models exploring chimeric antigen receptor T-cell (CAR-T) cell therapies in solid tumors. CAR T-cell therapies are customized for each individual patient. […]

June 28, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 27 Jun 2022

Eye inflammation leads to FDA partial clinical hold on Nuvation Bio solid tumor study

U.S. biopharma company Nuvation Bio Inc. says the Food and Drug Administration (FDA) has placed a partial clinical hold on the company’s phase 1 dose escalation study of NUV-422 in solid tumors, including high grade glioma, HR+/HER2- advanced breast cancer and metastatic castration resistant prostate cancer. The company’s Phase 1 trial began enrolling patients in […]

June 27, 2022 - 2 minutesmins - By Jim Cornall

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Cancer therapeutics company’s double win with $25M funding, and appointment of new board member

Beyond Biotech podcast 4: CorePath, Rensselaer, Versameb

World’s first research project for an early detection, multi-cancer screening test launched in Singapore

Destiny Pharma announces start of new oral mucositis research program

AstraZeneca adds to its treatments for blood cancer with $100M deal

Nanoparticle can kill cancer cells and aid muscle relaxation

License submitted to FDA for drug to help those with large B-cell lymphoma

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

Companies unite to bolster diagnostics for cancer and liver disease

Breast cancer drug recommended for approval

Trinity, St. James’s and Legend Biotech collaborating on solid tumors

Eye inflammation leads to FDA partial clinical hold on Nuvation Bio solid tumor study

Subscribe to our newsletter to get the latest biotech news!